Patent ID: 11857617
Assignee: TOPELIA AUST LIMITED (652 771 670)
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 5:
6. The method of claim 1, further comprising administering to a subject or an individual in need thereof:
(a) a booster,
(b) at least one second booster or follow-up administration of: at least one dosage of the live, inactivated or attenuated and causative agent of the infection, is given between about 1 week to one year, or between about two weeks to 9 months, or between about three weeks to 8 months, or between about one month to 7 months, or about 3, 4, 5, or 6 months, after the first administration of the live, inactivated or attenuated causative agent of the infection, or
(c) a third booster, wherein on day zero, or at least one day, or about two days, after, administration of a second or an additional booster dose of the live, inactivated or attenuated causative agent of the infection, is given, and the individual in need thereof is administered an additional dose of the anti-viral drug combination.